mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |